Watchlist Price Alert

Allogene Therapeutics Inc... (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.38

0.04 (2.99%)

At close: Jun 16, 2025, 10:28 AM

Allogene Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-257.59M	-327.26M	-332.63M	-257M	-250.22M	-184.59M	-211.5M	-24K
Depreciation & Amortization	13.64M	14.2M	14.29M	10.45M	7.59M	5.03M	1.5M	n/a
Stock-Based Compensation	51.74M	65.95M	83.6M	80.82M	65.26M	46.06M	18.57M	n/a
Other Working Capital	-24.3M	-7.8M	-1.16M	-31.32M	53.31M	-5.89M	3.3M	24K
Other Non-Cash Items	16.26M	24.69M	2.43M	2.61M	3.96M	3.36M	134.81M	n/a
Deferred Income Tax	443K	n/a	8.08M	10.4M	4.4M	-331K	-117K	n/a
Change in Working Capital	-24.8M	-15.3M	3.71M	-32.09M	53.92M	-6.88M	12.1M	24K
Operating Cash Flow	-200.3M	-237.73M	-220.52M	-184.81M	-115.09M	-137.35M	-44.65M	n/a
Capital Expenditures	-694K	-1.52M	-5.19M	-21.45M	-65.96M	-50.79M	-3.23M	n/a
Cash Acquisitions	n/a	n/a	-111.35M	-17.71M	439.17M	-5.08M	n/a	n/a
Purchase of Investments	-361.48M	-438.63M	-248.11M	-525.58M	-1.04B	-252.63M	-649.31M	n/a
Sales Maturities Of Investments	437.86M	603.43M	359.46M	728.39M	598.43M	472.58M	21.84M	n/a
Other Investing Acitivies	n/a	n/a	111.35M	185.1M	-439.17M	214.88M	-2.1M	n/a
Investing Cash Flow	75.69M	163.29M	106.16M	163.66M	-505.12M	164.08M	-632.8M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	116.84M	n/a
Common Stock Repurchased	1.53M	n/a	2.46M	3.62M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.28M	4.58M	2.95M	11.96M	11.66M	4.74M	654.34M	n/a
Financial Cash Flow	116.67M	95.69M	2.95M	11.96M	633.59M	58.96M	771.18M	n/a
Net Cash Flow	-7.94M	21.25M	-111.41M	-9.19M	13.38M	85.69M	93.73M	n/a
Free Cash Flow	-200.99M	-239.25M	-225.71M	-206.26M	-181.05M	-188.14M	-47.89M	n/a